Life Sciences Industry Report

Digital

One of the most remarkable shifts in modern healthcare is how seamlessly digital platforms are becoming part of the drug development journey.

News

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.